Publications by Convenors
- S. Ligthart (2026), Psychedelica in het Nederlandse drugsbeleid: Aanzet tot een grondige herbezinning, Nederlands Juristenblad 2026/401.
- Quigley, M. & Hayler, M. (2026), ‘A Psychedelic Research Agenda for Europe? Mapping Legal, Ethical, and Social Challenges’ in Faulkner, A. (ed.), A Biomedical Research Agenda for Science and Society (Edward Elgar).
- C. Bublitz (2026), How to Change Minds Ethically: Doxastic Vulnerability, Epistemic Harm Reduction, and the Role of Therapists in Psychedelic Therapy, Journal of Applied Philosophy 43, 2026, doi: 10.1111/japp.70053
- Quigley, M., Neill, J., & Downey, L. (2025), ‘Psychedelics Might Help Terminal Patients Find Peace’, The Conversation, 14 November.
- Neill, J. Downey, L. & Quigley, M (2025) ‘Easing End-of-Life Distress: Should Psychedelic Therapy Be Part of Palliative Care in the UK?‘ Drug Science Blog.
- Poppe, C., Bublitz, C., & Repantis, D. (2025). Offering Psychedelic Treatments Before Assisted Dying for Psychiatric Conditions. JAMA psychiatry. doi:10.1001/jamapsychiatry.2025.1457
- C. Bublitz & L. Böllinger (2024), Substanz und Modalität. Rechtliche Fragen der Regulierung psychedelisch-assistierter Therapien. Nervenheilkunde 5/2024, 275-283.
- C. Bublitz (2024), Zur strafrechtlichen Lage von Therapien mit Psychedelika. Medizinrecht 42, 26-32.
- Bublitz, C., Langlitz, N., and Repantis, D. (2023). “Control Side Effects of the Psychedelic Renaissance.” Natur 620, nein. 7973 (10. August 2023): 277–277. https://doi.org/10.1038/d41586-023-02495-8